Recent Updates
Recently added Catalysts
JNJ Positive Sentiment

Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2026

Wednesday, July 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Johnson & Johnson has declared a cash dividend of $1.34 per share for the third quarter of 2026. This dividend will be payable on September 8, 2026, to shareholders of record as of August 25, 2026. The announcement underscores the company's commitment to returning value to its shareholders.
Price reaction · baseline $253.85 (2026-07-14 close) · hit pre-market · clean, no other JNJ news in the window
day 0 close · peak
-2.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of a cash dividend reflects financial stability.
  • Dividend increase indicates confidence in future earnings.
  • Shareholders will benefit from consistent returns.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the third quarter of 2026 of $1.34 per share on the company’s common stock. The dividend is payable on September 8, 2026 to shareholders of record at the close of business on August 25, 2026. The ex-dividend date is August 25, 2026. About Johnson & Johnson At Johnson & Johnson, we believe health is everything. Our strength in healthcare inn

Frequently Asked Questions

What is the dividend amount declared by JNJ?

Johnson & Johnson has declared a cash dividend of $1.34 per share.

When will the dividend be paid?

The dividend will be payable on September 8, 2026.

What is the ex-dividend date for JNJ?

The ex-dividend date is August 25, 2026.

Who will receive the dividend?

Shareholders of record at the close of business on August 25, 2026, will receive the dividend.

ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare dividend third quarter 2026 cash dividend shareholders
Last updated: Jul 15, 2026

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CanagliflozinPhase 3
Diabetes Mellitus, Type 2 →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →